• Guidance
  • Interesting shortcuts
  • EFFRA Members' Perspectives
  • News Dashboard
  • Structured Wiki
    • Search
    • FoF and Made in Europe Partnership
    • Demonstrators, pilots, prototypes
    • Exploitable result(s)
    • Significant innovations and lessons learned, training aspects
    • Report - Video - Presentation - Publication....?
    • Project clusters
    • EFFRA member perspectives
    • Manufacturing future products
    • Manufacturing performance characteristics
    • Technologies and enablers
    • ICT performance characteristics
    • Standards, technical committees and working groups
    • Contribution of R&I projects to standardisation
    • Regulatory and policy aspects
    • Standards - other classifications
    • Business model aspects
    • Pathways
    • MiE SRIA R&I Priorities
    • MiE WP26-27 Consultation - Potential Research Topics only
    • MiE WP26-27 Consultation and context pointers
    • MiE WP26-27 Consultation with pointers to WP25-27 consultation
    • MiE KPIs
    • Relevant (future) calls
    • EU-Programme-Call
    • NACE code
    • EFFRA Organisations - members
    • EFFRA WG pointers
  • Pathways
    • Pathways
  • Projects
    • Projects
  • Resources
    • Resources
  • Project ideas
    • Project ideas
  • People & organisations
    • People
    • Organisations
  • portal@effra.eu
  • Visit the EFFRA website
    • Login
  • Structured Wiki
  • EU-Programme-Call
  • Horizon Europe
  • HORIZON.2 Global Challenges and European Industrial Competitiveness
  • HORIZON.2.1 Health
  • HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases

HORIZON.2.1.4 Infectious Diseases, including poverty-related and neglected diseases

  • HORIZON-HLTH-2021-CEPI-10-IBA
    • HORIZON-HLTH-2021-CEPI-10-01-IBA CEPI 3 - Contribution to the Coalition for Epidemics Preparedness Initiative
  • HORIZON-HLTH-2021-CORONA-01
    • HORIZON-HLTH-2021-CORONA-01-01 Vaccines & therapeutic clinical trials to boost COVID-19 prevention and treatment
    • HORIZON-HLTH-2021-CORONA-01-02 Cohorts united against COVID-19 variants of concern
  • HORIZON-HLTH-2021-DISEASE-04
    • HORIZON-HLTH-2021-DISEASE-04-03 Innovative approaches to enhance poverty-related diseases research in sub-Saharan Africa
    • HORIZON-HLTH-2021-DISEASE-04-05 A roadmap towards the creation of the European partnership on One Health antimicrobial resistance (OH AMR)
    • HORIZON-HLTH-2021-DISEASE-04-06 Building a European partnership for pandemic preparedness
    • HORIZON-HLTH-2021-DISEASE-04-07 Personalised medicine and infectious diseases: understanding the individual host response to viruses (e.g. SARS-CoV-2)
  • HORIZON-HLTH-2022-CEPI-15-IBA
    • HORIZON-HLTH-2022-CEPI-15-01-IBA CEPI 4 - Contribution to the Coalition for Epidemics Preparedness Initiative
  • HORIZON-HLTH-2022-DISEASE-06-two-stage
    • HORIZON-HLTH-2022-DISEASE-06-02-two-stage Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs
    • HORIZON-HLTH-2022-DISEASE-06-03-two-stage Vaccines 2.0 - developing the next generation of vaccines
  • HORIZON-HLTH-2022-DISEASE-07
    • HORIZON-HLTH-2022-DISEASE-07-01 Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
    • HORIZON-HLTH-2022-DISEASE-07-02 Pandemic preparedness
  • HORIZON-HLTH-2022-MPX-14
    • HORIZON-HLTH-2022-MPX-14-01 Clinical research response to the monkeypox public health emergency of international concern
  • HORIZON-HLTH-2023-CEPI-11-IBA
    • HORIZON-HLTH-2023-CEPI-11-01-IBA Contribution to the Coalition for Epidemics Preparedness Initiative (CEPI) - vaccine development for priority diseases
  • HORIZON-HLTH-2023-DISEASE-03
    • HORIZON-HLTH-2023-DISEASE-03-04 Pandemic preparedness and response: Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential
    • HORIZON-HLTH-2023-DISEASE-03-05 Pandemic preparedness and response: Sustaining established coordination mechanisms for European adaptive platform trials and/or for cohort networks
    • HORIZON-HLTH-2023-DISEASE-03-07 Relationship between infections and non-communicable diseases
    • HORIZON-HLTH-2023-DISEASE-03-17 Pandemic preparedness and response: Understanding vaccine induced-immunity
    • HORIZON-HLTH-2023-DISEASE-03-18 Pandemic preparedness and response: Immunogenicity of viral proteins of viruses with epidemic and pandemic potential
  • HORIZON-HLTH-2023-TOOL-05
    • HORIZON-HLTH-2023-TOOL-05-08 Pandemic preparedness and response: In vitro diagnostic devices to tackle cross-border health threats
  • HORIZON-JU-EDCTP3-2022-GH-Africa-IBA HORIZON-JU-GH-EDCTP3-2022-OA1 Grant to identified beneficiary - Support for an Africa office
  • HORIZON-JU-EDCTP3-2022-GH-Epidemiology-IBA HORIZON-JU-GH-EDCTP3-2022-OA2 Collaboration between GH EDCTP3 and the contributing Partner Bill & Melinda Gates Foundation: Genomic epidemiology for surveillance and control of poverty-related and emerging/re-emerging infections in sub-Saharan Africa
Powered by Chris Decubber BV